טוען...
Type 3 hypersensitivity in COVID-19 vasculitis
Coronavirus Disease 2019 (COVID-19) is an ongoing public health emergency and new knowledge about its immunopathogenic mechanisms is deemed necessary in the attempt to reduce the death burden, globally. For the first time in worldwide literature, we provide scientific evidence that in COVID-19 vascu...
שמור ב:
| הוצא לאור ב: | Clin Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256503/ https://ncbi.nlm.nih.gov/pubmed/32479986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2020.108487 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|